At a glance
- Originator Gilead Sciences
- Class Antihyperglycaemics; Antihypertensives; Antineoplastics; Hepatoprotectants; Small molecules
- Mechanism of Action MAP kinase kinase kinase 5 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Liver cancer; Liver cirrhosis
- No development reported Diabetic nephropathies; Pulmonary arterial hypertension